MedPath

A Phase III Long-Term Study of TK-041 in Patients with Pruritus Accompanied by Skin Diseases

Phase 3
Conditions
Eczema/dermatitis, Pruritus, Chronic Urticaria
Registration Number
JPRN-jRCT2080222735
Lead Sponsor
TEIKOKU SEIYAKU CO., LTD.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
180
Inclusion Criteria

Eczema/dermatitis
Pruritus
Chronic urticaria

Exclusion Criteria

Other skin diseases which interfere with the evaluation

Hypersensitivity to antihistamine drugs or study drug

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath